These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6174877)

  • 1. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.
    Perry EK; Blessed G; Tomlinson BE; Perry RH; Crow TJ; Cross AJ; Dockray GJ; Dimaline R; Arregui A
    Neurobiol Aging; 1981; 2(4):251-6. PubMed ID: 6174877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
    Perry EK; Perry RH
    Exp Brain Res; 1982; Suppl 5():140-5. PubMed ID: 6185355
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
    Perry EK; Tomlinson BE; Blessed G; Bergmann K; Gibson PH; Perry RH
    Br Med J; 1978 Nov; 2(6150):1457-9. PubMed ID: 719462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.
    Perry EK; Tomlinson BE; Blessed G; Perry RH; Cross AJ; Crow TJ
    J Neurol Sci; 1981 Aug; 51(2):279-87. PubMed ID: 7276979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptides in Alzheimer type dementia.
    Ferrier IN; Cross AJ; Johnson JA; Roberts GW; Crow TJ; Corsellis JA; Lee YC; O'Shaughnessy D; Adrian TE; McGregor GP
    J Neurol Sci; 1983 Dec; 62(1-3):159-70. PubMed ID: 6199464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides in Alzheimer's disease: a review and morphological results.
    Bouras C; de St Hilaire-Kafi S; Constantinidis J
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):271-86. PubMed ID: 2432629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of senile dementia].
    Karobath M
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1803-7. PubMed ID: 2868521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
    Perry EK; Gibson PH; Blessed G; Perry RH; Tomlinson BE
    J Neurol Sci; 1977 Nov; 34(2):247-65. PubMed ID: 144789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic system in old age and Alzheimer's disease.
    Perry EK
    Age Ageing; 1980 Feb; 9(1):1-8. PubMed ID: 7361631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Moroji T; Kosaka K
    Neurosci Lett; 1984 Nov; 52(1-2):73-8. PubMed ID: 6152043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity for glutamic acid decarboxylase and several neuropeptides in the spinal cord of the raccoon.
    Mark EK; Hauge DH; Standage GP; Doetsch GS
    Brain Res Bull; 1990 Nov; 25(5):787-90. PubMed ID: 1705158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical changes in the cholinergic system of the ageing brain and in senile dementia.
    Bowen DM; Davison AN
    Psychol Med; 1980 May; 10(2):315-9. PubMed ID: 6104344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome.
    Pierotti AR; Harmar AJ; Simpson J; Yates CM
    Neurosci Lett; 1986 Jan; 63(2):141-6. PubMed ID: 2869457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
    Davies P
    Brain Res; 1979 Aug; 171(2):319-27. PubMed ID: 37989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.